Jordan Smith profile



Jordan Smith
UserName : Jordan Smith
Joined: 2020-11-05
Account Status : Active

Articles by Jordan Smith

# Category Title
1healthThe contract manufacturing market for live biotherapeutics and microbiome
2healthThe non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030
3healthThe subcutaneous biologic drugs and affiliated technologies market
4healthThe synthetic lethality-based drugs and targets market
5healthThe Chinese biopharmaceutical contract manufacturing market
6healththe cell therapy manufacturing market is estimated to reach close to USD 11 Billion
7healthThe cell and advanced therapies supply chain management market
8healthThe bispecific antibody therapeutics market
9healthThe antibody drug conjugates market is estimated to be worth more than 15 billion in 2030
10healthThe Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rat
11health Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019
12healthGrowing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to r
13othersBiopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an exten
14othersThe biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 203
15healthMicrobial Contract Biomanufacturing Market, 2020-2030
16healthThe microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, gro
17healthIn Vitro ADME Testing Services Market, 2019-2030
18healthIn vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an a
19healthRoots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list
20healthThe global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growi
21healthPrefilled Syringe Fill / Finish Service Providers, 2020-2030
22healthThe prefilled syringe fill / finish services market is estimated to is estimated to reach close to U
23healthPrefilled Syringes Market (5th edition), 2019-2030
24healthPrefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the curren
25healthThe prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030
26healthThe prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots
27healthWith over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD
28healthRNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030
29healthThe “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an
30healthThe biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8
31healthThe biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 203
32othersBiologics Fill / Finish Service Providers, 2019-2030
33healthThe contract fill / finish services market for biologics market is projected to grow at an annualize
34othersThe contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion
35healthThe subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD
36health The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%,
37newsThe STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is an
38healthThe “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the curre
39healthThe targeted protein degradation market is projected to grow at an annualized rate of more than 30%
40healthSynthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair
41healthThe synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of
42healthThe synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 203
43healthThe “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the curre
44healthThe targeted protein degradation market is projected to grow at an annualized rate of more than 30%
45othersSynthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair
46healthThe synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of
47healthThe synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 203
48healthThe next generation contact lenses and visual prostheses market is estimated to be worth USD 3.7 bil
49healthGlobal Handheld Ultrasound Imaging Devices Market, 2020-2030
50healthThe global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 203
51healthThe global preventive vaccines market is projected to be worth USD 94 billion, by 2030, growing at a
52health The “Global Collaborative Robots (Cobots) Market, 2020-2030” report features an extensive study of
53othersThe global collaborative robots (cobots) market is projected to grow at an annualized rate of 34.4%,
54healthThe global collaborative robots (cobots) market is projected to be worth USD 18 billion by 2030, gro
55healthThe “STING Pathway Targeting Therapeutics and Technologies, 2020-2030” report features an extensive
56health The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%,
57healthThe STING pathway targeting technologies market, featuring a healthy pipeline of therapeutics, is an
58othersThe ‘Global Autoinjectors Market (3rd Edition), 2020-2030’ report features an extensive study of the
59healthThe global autoinjectors market is projected to grow at an annualized rate of ~10% and be worth arou
60healthThe global autoinjectors market is projected to grow at an annualized rate of over 10%, till 2030
61healthThe “Gene Therapy Market (3rd Edition), 2019-2030” report features an extensive study of the current
62healthThe gene therapy market is projected to grow at an annualized rate of 45%, till 2030
63newsThe gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis
64healthFragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report features an e
65health The fragment-based drug discovery market is projected to grow at an annualized rate of ~10%, till 2
66health The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade.
67healthThe endocannabinoid system targeted therapeutics market is projected to grow at an annualized rate of ~30%, till 2030
68healthThe endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030, growing at an annualized rate of 30%, claims Roots Analysis
69healthThe ‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures’ report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market.
70healthThe elastomeric closures market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis
71healthDrug Repurposing Service Providers Market, 2020-2030’’ report features an extensive study of the current market landscape and future opportunities for players offering services for repurposing / repositioning / reprofiling of drug candidates.
72healthThe drug repurposing service providers market is projected to grow at an annualized rate of 14.7%, till 2030
73healthDigital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030
74healthThe global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030, predicts Roots Analysis
75healthThe global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030, growing at a CAGR of 19.7%, claims Roots Analysis
76healthOver 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis
77healthThe contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%,
78healthThe contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis
79healthThe “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China.
80healthThe contract manufacturing market for Pharmaceuticals in China is projected to grow at an annualized rate of ~8.9%, till 2030
81healthThe Chines biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~13%, till 2030
82healthThe Chinese biopharmaceutical contract manufacturing market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis
83healthThe cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030
84healthThe cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, predicts Roots Analysis
85healthThe “Encapsulated Cell Therapies and Encapsulation Technologies Market” report features an extensive study of the current market landscape and future potential, offering an informed opinion on the likely adoption of these therapies / technologies over the coming decade.
86healthMore than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis
87healthGiven the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates, the encapsulated cell therapies and encapsulation technologies market is anticipated to evolve at a rapid pace over the next decade, predicts Roots Analysis
88healthThe “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030” report features an extensive study of the innovative software solutions that are being used to improve / optimize various supply chain-related processes of cell and advanced therapies.
89healthPresently, over 160 innovative, software enabled systems are being used to efficiently manage and streamline various aspects of the complex supply chain of cell and advanced therapies
90healthGiven the cost saving potential across different processes and operations, the cell and advanced therapies supply chain management market is projected to grow at an annualized rate of ~25% rapid till 2030
91healthOver 180 companies from different regions across the globe presently claim to provide services for the development of companion diagnostic tests, claims Roots Analysis
92healthThe Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030
93healthThe Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis
94healthThe “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030” report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)).
95healthPresently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers; majority of these tests are intended to facilitate important therapy-related decisions, claims Roots Analysis
96healthCancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030
97healthCancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
98othersContinuous Manufacturing Market (Small Molecules and Biologics), 2020 – 2030” report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers).
99healthOver 60 companies across the globe claim to manufacture drug products / drug substances using the continuous manufacturing technique, either for in-house requirements or for contract service engagements, claims Roots Analysis
100healthThe continuous manufacturing market is projected to grow at an annualized rate of over 15%, till 2030
101healthThe continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
102othersAntibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely future evolution in this industry over the next ten years
103healthOver 80 firms are involved in providing antibody drug discovery-related services; whereas close to 125 players are offering antibody discovery platforms
104health The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%, till 2030
105health The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030 instead the antibody discovery platforms market is anticipated to be worth close to USD 6 billion by 2030, predicts Roots Analysis
106healthGrowing at an annualized rate of over 9%, the antibody discovery services market is projected to be worth USD 6.5 billion by 2030; the antibody discovery platforms market is estimated to be worth close to USD 6 billion by 2030: Roots Analysis
107healthBispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
108healthThe bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030
109healthThe bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
110healthAntibody Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of antibodies.
111healthSeveral companies worldwide claim to possess the required expertise and infrastructure to offer contract manufacturing services for a variety of antibody-based products
112healthThe antibody contract manufacturing market is projected to grow at an annualized rate of 12%, till 2030
113healthThe antibody contract manufacturing market is estimated to be worth USD 17 billion in 2030, predicts Roots Analysis
114healthThe antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis
115healthThe “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.
116healthMore than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts
117healthThe targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
118healthThe “Biopharmaceutical Contract Manufacturing Market (3rd edition), 2019 – 2030” report features an extensive study on the contract service providers within the biopharmaceutical industry.
119healthOver 235 companies worldwide claim to offer contract manufacturing services for various types of biopharmaceutical drug / therapy products
120healthThe biopharmaceutical contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030
121healthThe biopharmaceutical contract manufacturing market is estimated to be worth USD 13.9 billion in 2030, predicts Roots Analysis
122healthSynthetic Lethality-based Drugs and Targets Market, 2019-2030
123healthAbout 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts
124healthThe synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030
125healthThe synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis
126healthMore than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis
127healthThe subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030
128healthThe subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis
129healthGlobal Stem Cells Market: Focus on Clinical Therapies, 2020–2030
130healthMore than 120 industry players are engaged in evaluating the potential of over 280 stem cell therapy products for the treatment of a variety of disease indications
131healthWith over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis
132healthThe “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.
133healthPresently, there are two approved drug and over 150 product candidates, which are being evaluated for the treatment of a variety of disease indications, based on the RNAi principle, claims Roots Analysis
134healthRNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030
135healthRNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis
136healthThe RNAi therapeutics market is anticipated to grow at an annualized rate of more than 45%, till 2030, claims Roots Analysis
137othersThe “Global Psychedelic Therapeutics Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of psychedelic therapeutics, over the next decade
138healthNearly 70 players from across the world presently claim to be engaged in the development and evaluation of therapeutic candidates based on a number of psychedelic compounds, such as ketamine and psilocybin, claims Roots Analysis
139healthGlobal Psychedelic therapeutics market is projected to grow at an annualized rate of ~15%, till 2030
140healthGlobal Psychedelic therapeutics market is estimated to be worth over USD 6.5 billion in 2030, predicts Roots Analysis
141healthProteome Profiling Services Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with proteome profiling service providers, offering detailed analysis of the key drivers and trends related to this evolving domain.
142healthThe market is fragmented, featuring the presence of both industry and non-industry players that are involved in providing proteome profiling services for various applications, claims Roots Analysis
143healthThe proteome profiling services market is projected to grow at an annualized rate of ~15%, till 2030
144healthThe proteome profiling services market is projected to be worth USD 16 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
145healthPrefilled Syringe Fill / Finish Service Providers, 2020-2030” report features an extensive study of the current market landscape and future opportunities for contract service providers offering fill finish services for prefilled syringes.
146healthOver 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees, claims Roots Analysis
147healthThe prefilled syringe fill / finish services market is projected to grow at an annualized rate of over 10%, till 2030
148healthThe prefilled syringe fill / finish services market is estimated to is estimated to reach close to USD 3 Billion by 2030, predicts Roots Analysis
149healthTo order this detailed 800+ page report, please visit this link Key Inclusions  An overview of the current market landscape of companies engaged in manufacturing prefilled syringes, providing information on year of establishment, company size, geographical location of the headquarters and manufacturing facilities, type of material used (glass and plastic), number of barrel chambers (single chamber and dual chamber), type of needle system (fixed needle system, luer lock and luer cone) and syringe volume.  An overview of the current market landscape of companies that are developing drugs in combination with prefilled syringes, featuring information on year of establishment, company size, geographical location of the developers, target therapeutic area, phases of development, type of drug molecule, route of administration, approval year (for marketed products), dosage details (for marketed products) and other approved dosage forms (for marketed products).  A detailed competitiveness analysis of the various prefilled syringes that we came across, taking into consideration the supplier power (based on the employee size of developer / manufacturer and their respective annual revenues) and key product specifications, such as number of chambers in the barrel, number of needle systems, volume of the barrel, technological advancement / user-friendliness and other distinguishing features.  A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with prefilled syringes in the near future, shortlisted based on an in-depth analysis that takes into consideration various relevant parameters, such as route of administration, type of drug molecule, target indications, other available dosage forms (for approved drugs) and historical annual sales information (for approved drugs).  An analysis presenting potential strategic partners (primarily drug developers) for prefilled syringe manufacturers (with regard to likely collaboration opportunities for combination product development) based on different parameters, such as pipeline strength, target therapeutic indication(s) and developer strength.  An analysis of the various prefilled syringe combination product-related initiatives of big pharma players, based on parameters, such as current adoption (based on number of approved and under development prefilled syringe combination products) and likely future adoption (based on potential injectable product candidates in the pipeline that are likely to be delivered via prefilled syringes), target therapeutic area(s) and type of drug molecule.  A review of the landscape of contract fill / finish services providers that offer services for prefilled syringes, featuring a list of active (large-sized) service providers and analysis based on a number of relevant parameters, such as year of establishment, company size, scale of operation (preclinical, clinical and commercial), type of drug molecule (biologics and small molecules), and geographical location of the service provider.  A detailed discussion on various safety features (add-on and integrated devices) installed in recent versions of prefilled syringes and the companies involved in developing and manufacturing such solutions.  An informative summary of various guidelines established and issued by major regulatory bodies for the approval of prefilled syringes, across different countries / geographical regions.  Brief discussions of currently available specialty syringes, which include prefilled flush syringes, prefilled diluent syringe systems and prefilled contrast agent delivery systems.  A case study on companies that are engaged in the manufacturing of autoinjectors, featuring brief profiles of key players in this domain; each profile includes an overview of the firm, and information on its respective product portfolio.  Elaborate profiles of prominent prefilled syringe manufacturers engaged in this domain, featuring a brief overview of the company, its financial information (if available), information on product portfolio, recent developments and an informed future outlook. The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:  Target therapeutic area  Autoimmune disorders  Infectious diseases  Neurological disorders  Blood disorders  Oncological disorders  Psychiatric disorders  Respiratory disorders  Cardiovascular disorders  Metabolic disorders  Ophthalmic diseases  Orthopedic disorders  Others  Type of syringe  Specialty syringes  Type of syringe barrel material  Glass  Plastic  Number of barrel chambers  Single chamber  Dual chamber  Key geographical regions  North America  Europe  Latin America  Asia Pacific  Middle East and Africa To request sample pages, please visit this link Key Questions Answered  Who are the key players engaged in the manufacturing of prefilled syringes, across the globe?  What are the prevalent trends within the prefilled syringes market?  What are the current regulatory requirements for securing marketing authorizations for prefilled syringe combination products, across different countries?  What technological advances have taken place in the prefilled syringes market?  What are the key growth drivers within the prefilled syringes market?  Who are the key contract service providers in this domain?  How is the current and future market opportunity likely to be distributed across key market segments? You may also be interested in the following titles: 1. Global Autoinjectors Market (3rd Edition), 2020-2030 2. Novel Vaccine Delivery Devices Market, 2019-2030 3. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030 4. Medical Device Labels Manufacturing Market, 2019 - 2030 Contact Us Gaurav Chaudhary +1 (415) 800 3415 [email protected]
150healthPresently, around 80 types of prefilled syringes are available in the market, and several companies claim to be engaged in the manufacturing of both glass and plastic variants of such versatile drug delivery solutions, claims Roots Analysis
151healthThe prefilled syringes market is projected to grow at an annualized rate of ~5%, till 2030
152healthThe prefilled syringes market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis
153healthThe “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.
154healthMore than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis
155healthRoots Analysis has announced the addition of “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report to its list of offerings.
156healthThe peptides and macrocycle drug discovery services market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis
157healthThe “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides.
158healthCurrently, around 50 companies claim to manufacture peptide-based therapeutics; such players also claim to be capable of providing a variety of additional services to their clients
159healthPeptide Therapeutics: Contract API manufacturing market is projected to grow at an annualized rate of ~11.2%, till 2030
160healthPeptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis
161healthThe ‘Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain.
162healthPresently, close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical and medical devices industries, employing a variety of outreach methods and solutions, claims Roots Analysis
163healthThe patient recruitment and retention services market is projected to grow at an annualized rate of ~5%, till 2030
164healthThe patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis
165healthThe “Ophthalmic Drugs Contract Manufacturing Market, 2020-2030” report features an extensive study of the contract services market for ophthalmic APIs and drug FDFs (including ophthalmic drops, emulsions, gels, injections, lotions, ointments, suspensions, and tablets / capsules)
166healthMore than 240 companies across the globe claim to have the required capabilities to offer variety of services on a contract basis, working at different scales of operation, for a wide range of ophthalmic APIs and drug FDFs, claims Roots Analysis
167healthThe ophthalmic drugs contract manufacturing market is projected to grow at an annualized rate of ~8%, till 2030
168healthThe ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
169healthThe “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.
170healthMore than 150 industry players across the world are presently engaged in evaluating the potential of nearly 300 next generation immune checkpoint modulators for the treatment of multiple disease indications, claims Roots Analysis
171healthThe next generation immune checkpoint inhibitors and stimulators market is projected to grow at an annualized rate of ~15%, till 2030
172healthThe next generation immune checkpoint inhibitors and stimulators market is estimated to be worth USD 12.5 billion in 2030, predicts Roots Analysis
173healthThe “Bispecific Antibody Therapeutics Market (4th Edition), 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
174health With two approved drugs and close to 300 clinical / preclinical product candidates, the bispecific antibody therapeutics pipeline has evolved significantly over the past few years, claims Roots Analysis
175healthThe bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030
176healthThe bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
177healthNeoantigen Targeted Therapies Market, 2019-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
178healthPresently, over 150 neoantigen targeted therapies are being evaluated for advanced cancer indications and are designed for delivery via different routes of administration
179healthThe neoantigen targeted therapies market is projected to grow at an annualized rate of 57%, till 2030
180healthThe neoantigen targeted therapies market is estimated to be worth USD 3 Billion in 2030, predicts Roots Analysis
181health Neoantigen targeted therapies market projected to reach USD 3 Billion by 2030, growing at an annualized rate of 57%, claims Roots Analysis
182healthMicrobial Contract Biomanufacturing Market, 2020-2030
183healthOver 115 companies, across the world, claim to offer a variety of product development, manufacturing and support services, for various types of biologics that are manufactured / expressed in microbial systems, claims Roots Analysis
184healthThe microbial contract biomanufacturing market is projected grow at an annualized rate of 8.7%, till 2030
185healthThe microbial contract biomanufacturing market is estimated to be worth USD 9.3 billion in 2030, predicts Roots Analysis
186healthThe microbial contract biomanufacturing market is projected to be worth USD 9.3 billion by 2030, growing at a CAGR of 8.7%, claims Roots Analysis
187healthThe “Medical Device Labels Manufacturing Market, 2019-2030” report features an extensive study of the current market landscape of companies offering manufacturing services for medical device labels.
188healthMore than 80 companies presently claim to have the required expertise to design and manufacture different types of labels, using both conventional and advanced printing methods, for use in medical devices, claims Roots Analysis
189healthThe medical device label contract manufacturing market is projected to grow at an annualized rate of ~9.8%, till 2030
190healthThe medical device label contract manufacturing market is projected to reach USD 509 million in 2030, predicts Roots Analysis
191healthThe ‘Contract Regulatory Affairs Management Market for Medical Devices, 2019-2030’ report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices.
192healthOver 400 companies claim to possess the required expertise to offer regulatory affairs management-related services to medical device-focused business entities, claims Roots Analysis
193healthThe contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%,
194healthThe contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis
195healthThe medical device label contract manufacturing market is projected to reach USD 509 million in 2030, predicts Roots Analysis